Decoding 5-moUTP Firefly Luciferase mRNA: Stability, Deliver
2026-05-31
Explore how Firefly Luciferase mRNA with 5-moUTP modification redefines mRNA delivery and protein expression stability. This article unveils unique mechanistic insights and practical advances for gene regulation and functional assays.
Neuromedin S (rat): Technical Parameters and Workflow Guidan
2026-05-30
Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for controlled activation of neuromedin U receptor signaling in rat-based GPCR/G protein research. It is intended for use in assays investigating energy homeostasis regulation and stress response, not for diagnostic or medical applications.
AG-120 (Ivosidenib): Optimized Workflows for Mutant IDH1 Inh
2026-05-29
AG-120 (Ivosidenib) offers researchers a precise, potent tool for targeting mutant IDH1-driven malignancies, enabling robust 2-hydroxyglutarate reduction and restoration of myeloid differentiation. This article delivers protocol enhancements, troubleshooting strategies, and practical insights—especially for overcoming CD44-mediated resistance in AML models.
Disulfiram: Dopamine β-Hydroxylase Inhibitor for Cancer Rese
2026-05-29
Disulfiram, a well-known dopamine β-hydroxylase inhibitor, is redefining cancer research by bridging ALDH2 inhibition, proteasome targeting, and synthetic lethality in genetically defined tumors. This guide translates the latest mechanistic insights and protocol optimizations into actionable workflows—empowering bench scientists to leverage Disulfiram with precision for apoptosis and tumor suppression studies.
GPR107 Deficiency Drives Collagen IV Accumulation in Diabeti
2026-05-28
Xu et al. reveal that GPR107 deficiency exacerbates diabetic nephropathy by disrupting collagen IV homeostasis in podocytes. Their mechanistic insights link impaired AT1R endocytosis and enhanced Ca2+ signaling to pathological extracellular matrix remodeling, highlighting GPR107 as a potential therapeutic target.
Optimizing hiPSC Platelet Differentiation: Yield and Cost Ad
2026-05-28
This study presents an optimized protocol for differentiating functional platelets from human induced pluripotent stem cells (hiPSCs), addressing yield, maturation efficiency, and cost barriers. By refining embryoid body input, culture medium, and integrating small molecule supplements, the protocol accelerates differentiation and increases platelet output, offering translational value for regenerative medicine.
Mitigating Pollen Interference in EEM Fluorescence for Hazar
2026-05-27
This study presents an advanced data-processing framework to distinguish hazardous substances from pollen contamination in excitation–emission matrix (EEM) fluorescence spectra. By integrating spectral transformation and random forest classification, the researchers achieved substantial gains in accuracy, offering a robust approach for rapid bioaerosol detection.
Dynasore (A1605): Reliable Dynamin GTPase Inhibition in Endo
2026-05-27
This article delivers scenario-driven, evidence-based guidance for using Dynasore (SKU A1605) as a dynamin GTPase inhibitor in endocytosis, viability, and cytotoxicity assays. Researchers will gain actionable insights on experimental design, protocol optimization, and vendor selection, grounded in peer-reviewed studies and practical lab experience.
GLP-1 (9-36) amide: Reliable Antagonism for GLP-1R Research
2026-05-26
GLP-1 (9-36) amide (SKU B5404) is a rigorously validated glucagon-like peptide-1 receptor antagonist that addresses key challenges in GPCR signaling and metabolic regulation studies. This article explores practical laboratory scenarios, emphasizing how B5404 enables reproducible, high-specificity data in diabetes and metabolic research. Researchers benefit from protocol-ready guidance and vendor reliability insights.
Recombinant Human Oncostatin M: Precision Tools for Cytokine
2026-05-26
Explore how Recombinant Human Oncostatin M (rh-Oncostatin M) enables advanced, reproducible cytokine assays and X-chromosome inactivation research. This article uniquely dissects biophysical properties, mechanistic insights, and protocol optimization for researchers seeking scientific rigor.
BCECF-AM: Precision Intracellular pH Measurement for Protein
2026-05-25
BCECF-AM empowers researchers to achieve highly accurate, ratiometric intracellular pH measurement in live plant and mammalian cells, unlocking real-time insights into secretory pathway dynamics. Its robust workflow and troubleshooting guidance, drawn from gold-standard protocols, set a new benchmark for high-content functional assays.
KU-55933 in DNA Damage Signaling: Beyond Cancer Cell Arrest
2026-05-25
Explore how KU-55933, a potent ATM kinase inhibitor, advances DNA damage response research and opens new frontiers in mitochondrial signaling and heart failure models. This article offers actionable insights and protocol guidance distinct from current literature.
Exo1: Advancing Exocytic Pathway Inhibition for Translationa
2026-05-24
Explore how Exo1 (methyl 2-(4-fluorobenzamido)benzoate) is reshaping membrane trafficking research through unique mechanistic inhibition, offering translational researchers a powerful tool for dissecting Golgi-ER traffic and tumor extracellular vesicle biology. This thought-leadership article bridges mechanistic insight with strategic guidance, drawing from recent breakthroughs in tumor metastasis inhibition and the evolving landscape of exocytic pathway research.
Optimized Sulfonamides for TB: Activity with Reduced CYP 2C9
2026-05-23
This study systematically optimized sulfonamide derivatives of sulfaphenazole, yielding compounds with strong anti-Mycobacterium tuberculosis activity and substantially lower CYP 2C9 inhibition. These findings advance safer anti-TB drug development by revealing key structure–activity relationships and highlighting candidates with favorable efficacy and drug interaction profiles.
NIR-Triggered Cobalt Single-Atom Enzyme for Multimodal Cance
2026-05-22
This study presents a cobalt single-atom enzyme anchored on hollow N-doped carbon spheres, activated by near-infrared (NIR) light, to synergistically boost photodynamic, photocatalytic, and photothermal cancer therapy. The findings demonstrate amplified generation of highly reactive oxygen species (hROS) and improved tumor ablation, with implications for noninvasive, function-preserving phototherapeutic strategies.
462 records 17/31 page Previous Next First page 上5页 1617181920 下5页 Last page